Breast Biopsy System Market Growth Report 2021 to 2031
The Breast Biopsy System Market is expected to register a CAGR of 6.1% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX million by 2031.
The report is segmented by Breast Biopsy System Market By Product Type (Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy, Biopsy Markers); Guidance Technology (Ultrasound-Guided, Mammography-Guided, Magnetic Resonance); End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Research Laboratories, Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Breast Biopsy System Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Breast Biopsy System Market Segmentation
By Product Type- Needle Aspiration
- Ultrasound-Guided
- Mammography-Guided
- Magnetic Resonance
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Research Laboratories
- Others
Strategic Insights
Breast Biopsy System Market Growth Drivers- Increasing Incidence of Breast Cancer: The market for breast biopsies is significantly influenced by the increase in breast cancer cases worldwide. Millions are diagnosed with breast cancer annually, making it the most frequent cancer among women globally, according to the World Health Organization. As a result, more screening and diagnostic techniques are required.
- Growing Awareness and Early Detection Initiatives: The significance of early breast cancer detection is now more widely recognized. The demand for biopsy operations as part of diagnostic protocols is rising as a result of public health campaigns and educational programs that promote breast cancer screenings.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Rising Healthcare Expenditure: Better access to cutting-edge medical technologies, such as breast biopsy equipment, is being made possible by rising healthcare spending, especially in growing economies in Latin America and Asia-Pacific. As healthcare facilities get better, this tendency is anticipated to result in significant market growth in these areas.
- Technological Developments:The market is expanding as a result of advancements in biopsy techniques, such as the creation of minimally invasive treatments like vacuum-assisted biopsies and core needle. Compared to conventional surgical techniques, these technologies provide faster recovery periods, less patient suffering, and increased diagnostic accuracy.
- Government Initiatives and Research Funding: In an effort to increase early detection rates, governments are putting more money into cancer research and putting screening programs into place. In addition to raising awareness, these programs increase demand for breast biopsy equipment as a component of all-encompassing cancer care plans.
- Shift Towards Minimally Invasive Procedures: Both patients and medical professionals are increasingly or risingly choosing less intrusive surgical treatments. As a result of this change, more sophisticated biopsy tools are being used, which is in line with patient preferences for less invasive and faster recovery methods.
- Enhanced Demand for Biopsy Procedures: More women are taking part in routine screening programs as awareness campaigns emphasize the value of early identification of breast cancer. Because suspicious findings frequently necessitate additional examination through biopsy to confirm or rule out cancer, this rise in screens results in a higher number of biopsies being conducted.
- Integration of Advanced Imaging Technologies: Improvements in imaging technologies like MRI and ultrasound that are utilized in conjunction with biopsies have also been brought about by increased knowledge. By enabling more precise lesion localization, these technologies improve biopsy operations' accuracy and diagnostic results.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- North America Leadership:Due to its strong public awareness campaigns on breast cancer screening, significant research capabilities, and robust healthcare infrastructure, North America continues to dominate the market for breast biopsy systems. This region's market share is largely attributed to its emphasis on early detection.The market for breast biopsies is expanding quickly in regions like Asia-Pacific because of rising healthcare costs and increased awareness of breast cancer screening, which is anticipated to promote the use of biopsy technologies in these regions.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Breast Biopsy System Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Breast Biopsy System Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Hospital segment held the largest share in 2023.
In Europe, the UK held the second largest share in 2023.
Enhanced Demand for Biopsy Procedures
North America held the largest share in 2023 and is expected to retain its dominance during the forecast period
Increasing Incidence of Breast Cancer
The Breast Biopsy System Market is estimated to witness a CAGR of 6.1% from 2023 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Breast Biopsy System Market - By Product Type
1.3.2 Breast Biopsy System Market - By Guidance Technology
1.3.3 Breast Biopsy System Market - By End User
1.3.4 Breast Biopsy System Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BREAST BIOPSY SYSTEM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BREAST BIOPSY SYSTEM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BREAST BIOPSY SYSTEM MARKET - GLOBAL MARKET ANALYSIS
6.1. BREAST BIOPSY SYSTEM - GLOBAL MARKET OVERVIEW
6.2. BREAST BIOPSY SYSTEM - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BREAST BIOPSY SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. NEEDLE ASPIRATION (FNA) BIOPSY
7.3.1. Overview
7.3.2. Needle Aspiration (FNA) Biopsy Market Forecast and Analysis
7.4. CORE NEEDLE BIOPSY
7.4.1. Overview
7.4.2. Core Needle Biopsy Market Forecast and Analysis
7.5. SURGICAL BIOPSY
7.5.1. Overview
7.5.2. Surgical Biopsy Market Forecast and Analysis
7.6. BIOPSY MARKERS
7.6.1. Overview
7.6.2. Biopsy Markers Market Forecast and Analysis
8. BREAST BIOPSY SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - GUIDANCE TECHNOLOGY
8.1. OVERVIEW
8.2. GUIDANCE TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. ULTRASOUND-GUIDED
8.3.1. Overview
8.3.2. Ultrasound-Guided Market Forecast and Analysis
8.4. MAMMOGRAPHY-GUIDED
8.4.1. Overview
8.4.2. Mammography-Guided Market Forecast and Analysis
8.5. MAGNETIC RESONANCE
8.5.1. Overview
8.5.2. Magnetic Resonance Market Forecast and Analysis
9. BREAST BIOPSY SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.5. DIAGNOSTIC CENTERS
9.5.1. Overview
9.5.2. Diagnostic Centers Market Forecast and Analysis
9.6. RESEARCH LABORATORIES
9.6.1. Overview
9.6.2. Research Laboratories Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. BREAST BIOPSY SYSTEM MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Breast Biopsy System Market Overview
10.1.2 North America Breast Biopsy System Market Forecasts and Analysis
10.1.3 North America Breast Biopsy System Market Forecasts and Analysis - By Product Type
10.1.4 North America Breast Biopsy System Market Forecasts and Analysis - By Guidance Technology
10.1.5 North America Breast Biopsy System Market Forecasts and Analysis - By End User
10.1.6 North America Breast Biopsy System Market Forecasts and Analysis - By Countries
10.1.6.1 United States Breast Biopsy System Market
10.1.6.1.1 United States Breast Biopsy System Market by Product Type
10.1.6.1.2 United States Breast Biopsy System Market by Guidance Technology
10.1.6.1.3 United States Breast Biopsy System Market by End User
10.1.6.2 Canada Breast Biopsy System Market
10.1.6.2.1 Canada Breast Biopsy System Market by Product Type
10.1.6.2.2 Canada Breast Biopsy System Market by Guidance Technology
10.1.6.2.3 Canada Breast Biopsy System Market by End User
10.1.6.3 Mexico Breast Biopsy System Market
10.1.6.3.1 Mexico Breast Biopsy System Market by Product Type
10.1.6.3.2 Mexico Breast Biopsy System Market by Guidance Technology
10.1.6.3.3 Mexico Breast Biopsy System Market by End User
10.2. EUROPE
10.2.1 Europe Breast Biopsy System Market Overview
10.2.2 Europe Breast Biopsy System Market Forecasts and Analysis
10.2.3 Europe Breast Biopsy System Market Forecasts and Analysis - By Product Type
10.2.4 Europe Breast Biopsy System Market Forecasts and Analysis - By Guidance Technology
10.2.5 Europe Breast Biopsy System Market Forecasts and Analysis - By End User
10.2.6 Europe Breast Biopsy System Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Breast Biopsy System Market
10.2.6.1.1 Germany Breast Biopsy System Market by Product Type
10.2.6.1.2 Germany Breast Biopsy System Market by Guidance Technology
10.2.6.1.3 Germany Breast Biopsy System Market by End User
10.2.6.2 France Breast Biopsy System Market
10.2.6.2.1 France Breast Biopsy System Market by Product Type
10.2.6.2.2 France Breast Biopsy System Market by Guidance Technology
10.2.6.2.3 France Breast Biopsy System Market by End User
10.2.6.3 Italy Breast Biopsy System Market
10.2.6.3.1 Italy Breast Biopsy System Market by Product Type
10.2.6.3.2 Italy Breast Biopsy System Market by Guidance Technology
10.2.6.3.3 Italy Breast Biopsy System Market by End User
10.2.6.4 Spain Breast Biopsy System Market
10.2.6.4.1 Spain Breast Biopsy System Market by Product Type
10.2.6.4.2 Spain Breast Biopsy System Market by Guidance Technology
10.2.6.4.3 Spain Breast Biopsy System Market by End User
10.2.6.5 United Kingdom Breast Biopsy System Market
10.2.6.5.1 United Kingdom Breast Biopsy System Market by Product Type
10.2.6.5.2 United Kingdom Breast Biopsy System Market by Guidance Technology
10.2.6.5.3 United Kingdom Breast Biopsy System Market by End User
10.2.6.6 Rest of Europe Breast Biopsy System Market
10.2.6.6.1 Rest of Europe Breast Biopsy System Market by Product Type
10.2.6.6.2 Rest of Europe Breast Biopsy System Market by Guidance Technology
10.2.6.6.3 Rest of Europe Breast Biopsy System Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Breast Biopsy System Market Overview
10.3.2 Asia-Pacific Breast Biopsy System Market Forecasts and Analysis
10.3.3 Asia-Pacific Breast Biopsy System Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Breast Biopsy System Market Forecasts and Analysis - By Guidance Technology
10.3.5 Asia-Pacific Breast Biopsy System Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Breast Biopsy System Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Breast Biopsy System Market
10.3.6.1.1 Australia Breast Biopsy System Market by Product Type
10.3.6.1.2 Australia Breast Biopsy System Market by Guidance Technology
10.3.6.1.3 Australia Breast Biopsy System Market by End User
10.3.6.2 China Breast Biopsy System Market
10.3.6.2.1 China Breast Biopsy System Market by Product Type
10.3.6.2.2 China Breast Biopsy System Market by Guidance Technology
10.3.6.2.3 China Breast Biopsy System Market by End User
10.3.6.3 India Breast Biopsy System Market
10.3.6.3.1 India Breast Biopsy System Market by Product Type
10.3.6.3.2 India Breast Biopsy System Market by Guidance Technology
10.3.6.3.3 India Breast Biopsy System Market by End User
10.3.6.4 Japan Breast Biopsy System Market
10.3.6.4.1 Japan Breast Biopsy System Market by Product Type
10.3.6.4.2 Japan Breast Biopsy System Market by Guidance Technology
10.3.6.4.3 Japan Breast Biopsy System Market by End User
10.3.6.5 South Korea Breast Biopsy System Market
10.3.6.5.1 South Korea Breast Biopsy System Market by Product Type
10.3.6.5.2 South Korea Breast Biopsy System Market by Guidance Technology
10.3.6.5.3 South Korea Breast Biopsy System Market by End User
10.3.6.6 Rest of Asia-Pacific Breast Biopsy System Market
10.3.6.6.1 Rest of Asia-Pacific Breast Biopsy System Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Breast Biopsy System Market by Guidance Technology
10.3.6.6.3 Rest of Asia-Pacific Breast Biopsy System Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Breast Biopsy System Market Overview
10.4.2 Middle East and Africa Breast Biopsy System Market Forecasts and Analysis
10.4.3 Middle East and Africa Breast Biopsy System Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Breast Biopsy System Market Forecasts and Analysis - By Guidance Technology
10.4.5 Middle East and Africa Breast Biopsy System Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Breast Biopsy System Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Breast Biopsy System Market
10.4.6.1.1 South Africa Breast Biopsy System Market by Product Type
10.4.6.1.2 South Africa Breast Biopsy System Market by Guidance Technology
10.4.6.1.3 South Africa Breast Biopsy System Market by End User
10.4.6.2 Saudi Arabia Breast Biopsy System Market
10.4.6.2.1 Saudi Arabia Breast Biopsy System Market by Product Type
10.4.6.2.2 Saudi Arabia Breast Biopsy System Market by Guidance Technology
10.4.6.2.3 Saudi Arabia Breast Biopsy System Market by End User
10.4.6.3 U.A.E Breast Biopsy System Market
10.4.6.3.1 U.A.E Breast Biopsy System Market by Product Type
10.4.6.3.2 U.A.E Breast Biopsy System Market by Guidance Technology
10.4.6.3.3 U.A.E Breast Biopsy System Market by End User
10.4.6.4 Rest of Middle East and Africa Breast Biopsy System Market
10.4.6.4.1 Rest of Middle East and Africa Breast Biopsy System Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Breast Biopsy System Market by Guidance Technology
10.4.6.4.3 Rest of Middle East and Africa Breast Biopsy System Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Breast Biopsy System Market Overview
10.5.2 South and Central America Breast Biopsy System Market Forecasts and Analysis
10.5.3 South and Central America Breast Biopsy System Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Breast Biopsy System Market Forecasts and Analysis - By Guidance Technology
10.5.5 South and Central America Breast Biopsy System Market Forecasts and Analysis - By End User
10.5.6 South and Central America Breast Biopsy System Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Breast Biopsy System Market
10.5.6.1.1 Brazil Breast Biopsy System Market by Product Type
10.5.6.1.2 Brazil Breast Biopsy System Market by Guidance Technology
10.5.6.1.3 Brazil Breast Biopsy System Market by End User
10.5.6.2 Argentina Breast Biopsy System Market
10.5.6.2.1 Argentina Breast Biopsy System Market by Product Type
10.5.6.2.2 Argentina Breast Biopsy System Market by Guidance Technology
10.5.6.2.3 Argentina Breast Biopsy System Market by End User
10.5.6.3 Rest of South and Central America Breast Biopsy System Market
10.5.6.3.1 Rest of South and Central America Breast Biopsy System Market by Product Type
10.5.6.3.2 Rest of South and Central America Breast Biopsy System Market by Guidance Technology
10.5.6.3.3 Rest of South and Central America Breast Biopsy System Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BREAST BIOPSY SYSTEM MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. BREAST BIOPSY SYSTEM MARKET, KEY COMPANY PROFILES
13.1. BIOMED DIAGNOSTICS, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BARD PERIPHERAL VASCULAR INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. F. HOFFMANN-LA ROCHE LTD.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. HOLOGIC INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. LEICA BIOSYSTEMS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ONCOCYTE CORPORATION
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BECTON, DICKSON AND COMPANY
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. DANAHER CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MEDTRONIC PLC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Biomed Diagnostics, Inc.,
2. Bard Peripheral Vascular Inc.
3. F. Hoffmann-La Roche Ltd.
4. Hologic Inc.
5. Leica Biosystems
6. OncoCyte Corporation
7. Laboratory Corporation of America Holdings (Labcorp)
8. Becton, Dickson and Company
9. Danaher Corporation
10. Medtronic plc
11. Scion Medical Technologies LLC
12. Cook Medical LLC
13. Argon Medical Devices Inc.
14. Sterylab S.R.L
15. Planmed Oy
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For